Author:
A Griffin Karen,Pothugunta Krishna,Polichnowski Aaron J,Bidani Anil K
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference97 articles.
1. U.S. Renal Data system (USRDS 2012 Annual Data Report. Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
2. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men: 16-year MRFIT findings. JAMA. 1997;277:1293–8.
3. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarron C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005;165:923–8.
4. Kao WH, Klag MJ, Meoni LA, et al. Family Investigation of Nephropathy and Diabetes Research Group: MYH9 is associated with nondiabetic end-stage renal disease in African-Americans. Nat Genet. 2008;40:1185–92.
5. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic apoL1 variants with kidney disease in African-Americans. Science. 2010;329:841–5. Provides fairly definitive evidence of a genetic basis for the increased susceptibility to progressive kidney disease and ESRD in the African-American population.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献